FDA Inspection
K.C. Pharmaceuticals, IncK.C. Pharmaceuticals, Inc – FDA Inspection, Nov 16, 2017
Record Details
This FDA Inspection record concerns K.C. Pharmaceuticals, Inc, with an inspection on November 16, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 643dc654-deba-47c6-ac43-ac4a9c15f43b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1032267
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.180(b)Record maintenance 1 year (except exempt OTC)
- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.194(a)Complete test data included in records
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.160(a)Lab controls established, including changes
Full citation text and observation details available on the Dashboard.
Other FDA inspections of K.C. Pharmaceuticals, Inc
10| Date | Classification | Office | Project area |
|---|---|---|---|
| February 13, 2026 | Not classified | Los Angeles District Office | Drug Quality Assurance |
| August 28, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 13, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 30, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 19, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for K.C. Pharmaceuticals, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.